The relationship between when we eat and how our bodies respond is emerging as one of the most clinically significant ...
According to the experts, people with unexplained iron deficiency, persistent low vitamin B12, recurrent indigestion, or a ...
Obesity-focused clinical-stage biotechnology company Kalohexis on Tuesday confidentially filed to go public in the ​U.S., adding to an activity rebound ‌in the initial public offering market.
Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people ...
Researchers have identified 15-PGDH enzyme inhibition as a neuroprotective strategy in Parkinson's disease, with repurposable ...
Autophagy is the process by which cells remove damaged proteins, recycle worn-out organelles (e.g., mitochondria), clear ...
(RNS) — It should be a contradiction that the Confederate flag was marched alongside the Betsy Ross flag through the streets near the U.S. Capitol on Independence Day. The rebel banner was brought to ...
New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...
The kitchen at the Reznikov household in Armonk is already busy as Rachel, Daniella and their mother, Elina, start their day baking another fresh loaf of sourdough bread. The trio had always loved ...
One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...
Neuropeptides are brain and body signaling molecules that shape emotion, pain, metabolism, cognition, and immune function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results